Straumann Holding Ag · SIX:STMN
Straumann — Q1 2024 Earnings Presentation
11 slides from Straumann's earnings presentation, Apr 30, 2024
Slide 1: Webcast for investors, analysts and media
Webcast for investors, analysts and media Basel, 30 April, 2024 1 1 This presentation contains forward-looking statements that reflect the current views of management, and which are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achi
Slide 2: Highlights, Financials, Strategy, Outlook, Q&A
Highlights Guillaume Daniellot Financials Yang Xu Recent achievements & strategy Guillaume Daniellot Outlook 2024 Guillaume Daniellot Q&A and upcoming events Guillaume Daniellot, Yang Xu 3 3 Guillaume Daniellot, CEO 4 4
Slide 3: Q1 2024 highlights: revenue and regional performance
Revenue in CHF Organic revenue growth1 Regional performance 644m 15.1% China dynamic demand in most of our business or 8.1% in CHF exceptional organic growth boosted by segments continued strong momentum and low comparison base Implantology Orthodontics Outlook 20242 confirmed High single-digit iExc
Slide 4: Yang Xu, Chief Financial Officer
Yang Xu, Chief Financial Officer 7 Regional % share of +8.1% +15.1% organic growth Organic 5 644 59 6 LATAM 7 NAM 17 EMEA 596 6 14 7 559 -43 70 APAC Change in organic growth +5.2% +3.7% +82.0% +11.5% Net Revenue FX effect * M&A effect Adjusted EMEA NAM APAC LATAM Net Revenue Q1 2024 Q1 2023 Revenue
Slide 5: Tooth replacement and restoration
Tooth replacement Tooth alignment Digital solutions and restoration 9 9 Guillaume Daniellot, CEO 10 10
Slide 6: Market size and share by segment
6 5.3 5.3 5 Innovation 4 2.7 2.9 3 2.4 2 Education 1 0.7 >50% <5% ~5% ~5% ~15% >15% 0 Clinical Premium Non-premium ClearAligner Regeneratives CADCAM CADCAM Implantology Implantology equipment prosthetics evidence Market size Market share in CHF bn 11 Source: Straumann Group estimates 11 800 700 600
Slide 7: Value implant market opportunity by region
new 13 13 13 VALUE IMPLANT MARKET NAM EMEA ~31 MILLION IMPLANTS1 NAM EMEA LATAM APAC LATAM APAC Straumann Group share Market opportunity 14 1 Straumann Group estimates; market share by end of 2023 14
Slide 8: Software & Platform Integration
Software & Platform Integration Straumann UI/UX 15 15 CBCT IOS Clear Aligner Smile in a Box Scan & Shape 16 16
Slide 9: Technology, Service, Commercialization
Technology Service Commercialization ClearPilot 8.0 Center in Costa Rica Ortho Sales Academy 17 17 Capacity expansion Technology People Straumann AXS Shanghai Campus, China Digital customer platform EDGE!UP 18 18
Slide 10: Outlook 2024: market environment and revenue and profitability
19 Market environment and assumption Revenue and profitability • Uncertain economic environment remains • Organic revenue growth in the high single-digit percentage range • Group believes global patient flow should remain stable • Profitability at around 26% at constant 2023 currency rates or betwee
Slide 11: Upcoming events
21 21 2024 Event Location 15 May Deutsche Bank Q1 Roadshow Frankfurt 16 May Mirabaud Swiss Equity Conference Geneva 5 June BNP Paribas Exane Conference Paris 11 June Stifel Swiss Equities Conference Interlaken 20 June JP Morgan European HC Conference London 27 June Stifel European HC Conference Lyon